Join
Live feed
·
PRReleasevia Quantisnow
Research Alliance Corp. II logo
Therapeutics Acquisition Corp. logo

POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility

ByQuantisnow·Wall Street's wire, on your screen.